foxo4-dri senolytic 2023 Development of a novel by precise disruption of FOXO4-p53 complex FOXO4-DRI 10MG | Alpha Omega
FOXO4 DRI 10MG Alpha Omega Peptide The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway FOXO4 DRI Results: What to Expect (2026)
Pay in 4 interest-free payments of $5.21 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



